Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Nuclear Imaging Devices Market

ID: MRFR/MED/17928-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026

US Nuclear Imaging Devices Market Research Report: Size, Share, Trend Analysis By End Users (Hospitals, Diagnostic Imaging Centers, Others), By Applications (Oncology, Cardiology, Neurology, Others) and By Technology (PET, SPECT) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Nuclear Imaging Devices Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Cardiology
  50.     4.1.2 Oncology
  51.     4.1.3 Neurology
  52.     4.1.4 Thyroid Function
  53.   4.2 Healthcare, BY Product Type (USD Million)
  54.     4.2.1 Single Photon Emission Computed Tomography
  55.     4.2.2 Positron Emission Tomography
  56.     4.2.3 Hybrid Imaging Systems
  57.   4.3 Healthcare, BY End Use (USD Million)
  58.     4.3.1 Hospitals
  59.     4.3.2 Diagnostic Centers
  60.     4.3.3 Research Institutions
  61.   4.4 Healthcare, BY Technology (USD Million)
  62.     4.4.1 Cobalt-60
  63.     4.4.2 Technetium-99m
  64.     4.4.3 Gallium-68
  65. 5 SECTION V: COMPETITIVE ANALYSIS
  66.   5.1 Competitive Landscape
  67.     5.1.1 Overview
  68.     5.1.2 Competitive Analysis
  69.     5.1.3 Market share Analysis
  70.     5.1.4 Major Growth Strategy in the Healthcare
  71.     5.1.5 Competitive Benchmarking
  72.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  73.     5.1.7 Key developments and growth strategies
  74.       5.1.7.1 New Product Launch/Service Deployment
  75.       5.1.7.2 Merger & Acquisitions
  76.       5.1.7.3 Joint Ventures
  77.     5.1.8 Major Players Financial Matrix
  78.       5.1.8.1 Sales and Operating Income
  79.       5.1.8.2 Major Players R&D Expenditure. 2023
  80.   5.2 Company Profiles
  81.     5.2.1 Siemens Healthineers (DE)
  82.       5.2.1.1 Financial Overview
  83.       5.2.1.2 Products Offered
  84.       5.2.1.3 Key Developments
  85.       5.2.1.4 SWOT Analysis
  86.       5.2.1.5 Key Strategies
  87.     5.2.2 GE Healthcare (GB)
  88.       5.2.2.1 Financial Overview
  89.       5.2.2.2 Products Offered
  90.       5.2.2.3 Key Developments
  91.       5.2.2.4 SWOT Analysis
  92.       5.2.2.5 Key Strategies
  93.     5.2.3 Philips Healthcare (NL)
  94.       5.2.3.1 Financial Overview
  95.       5.2.3.2 Products Offered
  96.       5.2.3.3 Key Developments
  97.       5.2.3.4 SWOT Analysis
  98.       5.2.3.5 Key Strategies
  99.     5.2.4 Canon Medical Systems (JP)
  100.       5.2.4.1 Financial Overview
  101.       5.2.4.2 Products Offered
  102.       5.2.4.3 Key Developments
  103.       5.2.4.4 SWOT Analysis
  104.       5.2.4.5 Key Strategies
  105.     5.2.5 Elekta (SE)
  106.       5.2.5.1 Financial Overview
  107.       5.2.5.2 Products Offered
  108.       5.2.5.3 Key Developments
  109.       5.2.5.4 SWOT Analysis
  110.       5.2.5.5 Key Strategies
  111.     5.2.6 Medtronic (IE)
  112.       5.2.6.1 Financial Overview
  113.       5.2.6.2 Products Offered
  114.       5.2.6.3 Key Developments
  115.       5.2.6.4 SWOT Analysis
  116.       5.2.6.5 Key Strategies
  117.     5.2.7 Hitachi Medical Corporation (JP)
  118.       5.2.7.1 Financial Overview
  119.       5.2.7.2 Products Offered
  120.       5.2.7.3 Key Developments
  121.       5.2.7.4 SWOT Analysis
  122.       5.2.7.5 Key Strategies
  123.     5.2.8 Hologic (US)
  124.       5.2.8.1 Financial Overview
  125.       5.2.8.2 Products Offered
  126.       5.2.8.3 Key Developments
  127.       5.2.8.4 SWOT Analysis
  128.       5.2.8.5 Key Strategies
  129.   5.3 Appendix
  130.     5.3.1 References
  131.     5.3.2 Related Reports
  132. 6 LIST OF FIGURES
  133.   6.1 MARKET SYNOPSIS
  134.   6.2 US MARKET ANALYSIS BY APPLICATION
  135.   6.3 US MARKET ANALYSIS BY PRODUCT TYPE
  136.   6.4 US MARKET ANALYSIS BY END USE
  137.   6.5 US MARKET ANALYSIS BY TECHNOLOGY
  138.   6.6 KEY BUYING CRITERIA OF HEALTHCARE
  139.   6.7 RESEARCH PROCESS OF MRFR
  140.   6.8 DRO ANALYSIS OF HEALTHCARE
  141.   6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  142.   6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  143.   6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
  144.   6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  145.   6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  146.   6.14 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  147.   6.15 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
  148.   6.16 HEALTHCARE, BY END USE, 2024 (% SHARE)
  149.   6.17 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
  150.   6.18 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  151.   6.19 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
  152.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  153. 7 LIST OF TABLES
  154.   7.1 LIST OF ASSUMPTIONS
  155.     7.1.1
  156.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  157.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  158.     7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
  159.     7.2.3 BY END USE, 2025-2035 (USD Million)
  160.     7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
  161.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  162.     7.3.1
  163.   7.4 ACQUISITION/PARTNERSHIP
  164.     7.4.1

US Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

  • Cardiology
  • Oncology
  • Neurology
  • Thyroid Function

Healthcare By Product Type (USD Million, 2025-2035)

  • Single Photon Emission Computed Tomography
  • Positron Emission Tomography
  • Hybrid Imaging Systems

Healthcare By End Use (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Centers
  • Research Institutions

Healthcare By Technology (USD Million, 2025-2035)

  • Cobalt-60
  • Technetium-99m
  • Gallium-68

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions